Paper8610340
Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.
Kaplon RJ and 10 others. Transplantation, 1996. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival. Papers, record 8610340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8610340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD58 Antigens | Major topic |
| Heart Transplantation | Major topic |
| Immunoglobulin G | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| CD2 Antigens | |
| Graft Rejection | |
| Graft Survival | |
| Humans | |
| Immunotherapy | |
| In Vitro Techniques | |
| Lymphocyte Culture Test, Mixed | |
| Papio | |
| Recombinant Fusion Proteins | |
| Time Factors | |
| Transplantation, Heterotopic | |
| Transplantation, Homologous |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01163799 | A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients | Background |
Source ClinicalTrials.gov
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30455699 | In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/30455699 | PubMed |
| 27110598 | Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir? | Immunotherapy (Los Angel) | 2015 | https://conductscience.org/library/papers/27110598 | PubMed |
| 26095669 | Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. | Biol Blood Marrow Transplant | 2015 | https://conductscience.org/library/papers/26095669 | PubMed |
| 24003248 | Primate models in organ transplantation. | Cold Spring Harb Perspect Med | 2013 | https://conductscience.org/library/papers/24003248 | PubMed |
| 23818516 | Lymphodepletional strategies in transplantation. | Cold Spring Harb Perspect Med | 2013 | https://conductscience.org/library/papers/23818516 | PubMed |
| 20964456 | Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits. | Drugs | 2010 | https://conductscience.org/library/papers/20964456 | PubMed |
| 20125095 | Advances in immunosuppression for renal transplantation. | Nat Rev Nephrol | 2010 | https://conductscience.org/library/papers/20125095 | PubMed |
| 16247429 | Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report. | Bone Marrow Transplant | 2005 | https://conductscience.org/library/papers/16247429 | PubMed |
| 16190751 | Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation. | J Med Chem | 2005 | https://conductscience.org/library/papers/16190751 | PubMed |
| 10490759 | Gene therapy in transplantation. | Gene Ther | 1999 | https://conductscience.org/library/papers/10490759 | PubMed |
| 10357807 | Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies. | EMBO J | 1999 | https://conductscience.org/library/papers/10357807 | PubMed |
| 9339960 | Prevention of transplant rejection: current treatment guidelines and future developments. | Drugs | 1997 | https://conductscience.org/library/papers/9339960 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| CD58 | 965 | PubTator's text mining | https://conductscience.org/library/genes/965 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8610340
GET https://conductscience.org/api/papers/v1/8610340/authors